Conference Reports for NATAP

Conference on Retroviruses and Opportunistic Infections Seattle, Washington Feb 19-22 2023 Back

Tweet

Weight Gain at CROI 2023       CROI: Weight Gain: Does what Goes Up Come Down ? Themed Discussion - (03/27/23)   CROI: Changes in Body Mass Index with Longer-Term Integrase Inhibitor Use in REPRIEVE - (03/20/23)   CROI: Weight and Metabolic Changes With Cabotegravir + Rilpivirine Long-Acting or Bictegravir/Emtricitabine/Tenofovir Alafenamide - (02/23/23)   CROI: REVERSIBILITY OF TAF- AND/OR INSTI-ASSOCIATED WEIGHT GAIN - (02/24/23)   CROI: Weight and Metabolic Benefits With TDF/FTC/DTG After 4 Years of TAF/FTC+DTG - Mark Mascolini (02/24/23)   CROI: FAVORABLE METABOLIC OUTCOMES 48 WEEKS AFTER SWITCH TO DTG/3TC - (02/24/23)   CROI: Weight Gain Among Participants Switching to a Dolutegravir-based HIV Regimen in Kenya - (02/24/23)   CROI: FAVORABLE METABOLIC OUTCOMES 48 WEEKS AFTER SWITCH TO DTG/3TC - (02/24/23)   CROI: Weight and Metabolic Changes With Cabotegravir + Rilpivirine Long-Acting or Bictegravir/Emtricitabine/Tenofovir Alafenamide - (02/23/23)   CROI: VISCERAL FAT REDUCTION WITH TESAMORELIN ASSOCIATED WITH METABOLIC SYNDROME REVERSAL - (03/01/23)   CROI: PERICORONARY ADIPOSE TISSUE DENSITY AND SUBCLINICAL CORONARY ARTERY DISEASE IN HIV - (03/07/23)   CROI: A 12-WEEK MULTICOMPONENT EXERCISE PROGRAM REVERSES FRAILTY IN OLDER ADULTS WITH HIV - (03/16/23)   CROI: SEX DIFFERENCES IN THE ASSOCIATION OF HIV WITH METABOLIC-FATTY LIVER DISEASE - (03/16/23)   CROI: Subcutaneous Adipose Tissue Cell Composition is Associated with Visceral Fat Volume - (03/01/23)